vs
Side-by-side financial comparison of TechTarget, Inc. (TTGT) and VIEMED HEALTHCARE, INC. (VMD). Click either name above to swap in a different company.
TechTarget, Inc. is the larger business by last-quarter revenue ($140.7M vs $76.2M, roughly 1.8× VIEMED HEALTHCARE, INC.). VIEMED HEALTHCARE, INC. runs the higher net margin — 7.4% vs -6.7%, a 14.1% gap on every dollar of revenue. TechTarget, Inc. produced more free cash flow last quarter ($11.6M vs $9.7M).
TechTarget, Inc. is an American company that offers data-driven marketing services to business-to-business technology vendors.
Viemed Healthcare, Inc. is a medical technology firm specializing in respiratory care solutions. It develops, manufactures and distributes portable ventilators, respiratory therapy devices and related support services, catering to acute care, post-acute care and home care segments across North America, Europe and key Asia-Pacific markets for patients with respiratory conditions.
TTGT vs VMD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $140.7M | $76.2M |
| Net Profit | $-9.5M | $5.6M |
| Gross Margin | 63.8% | 57.9% |
| Operating Margin | -10.5% | 11.0% |
| Net Margin | -6.7% | 7.4% |
| Revenue YoY | — | 25.5% |
| Net Profit YoY | — | 30.7% |
| EPS (diluted) | $-0.09 | $0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $140.7M | $76.2M | ||
| Q3 25 | $122.3M | $71.9M | ||
| Q2 25 | $119.9M | $63.1M | ||
| Q1 25 | $103.9M | $59.1M | ||
| Q4 24 | — | $60.7M | ||
| Q3 24 | $62.9M | $58.0M | ||
| Q2 24 | — | $55.0M | ||
| Q1 24 | — | $50.6M |
| Q4 25 | $-9.5M | $5.6M | ||
| Q3 25 | $-76.8M | $3.5M | ||
| Q2 25 | $-398.7M | $3.2M | ||
| Q1 25 | $-523.4M | $2.6M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | $-17.4M | $3.9M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | — | $1.6M |
| Q4 25 | 63.8% | 57.9% | ||
| Q3 25 | 61.3% | 57.5% | ||
| Q2 25 | 57.3% | 58.3% | ||
| Q1 25 | 57.5% | 56.3% | ||
| Q4 24 | — | 59.5% | ||
| Q3 24 | 62.1% | 59.3% | ||
| Q2 24 | — | 59.8% | ||
| Q1 24 | — | 58.9% |
| Q4 25 | -10.5% | 11.0% | ||
| Q3 25 | -88.2% | 7.8% | ||
| Q2 25 | -342.1% | 8.1% | ||
| Q1 25 | -474.5% | 6.5% | ||
| Q4 24 | — | 10.6% | ||
| Q3 24 | -22.9% | 9.7% | ||
| Q2 24 | — | 6.6% | ||
| Q1 24 | — | 4.4% |
| Q4 25 | -6.7% | 7.4% | ||
| Q3 25 | -62.8% | 4.9% | ||
| Q2 25 | -332.4% | 5.0% | ||
| Q1 25 | -503.8% | 4.4% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | -27.7% | 6.7% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 3.2% |
| Q4 25 | $-0.09 | $0.14 | ||
| Q3 25 | $-1.07 | $0.09 | ||
| Q2 25 | $-5.58 | $0.08 | ||
| Q1 25 | $-7.32 | $0.06 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | $-0.42 | $0.10 | ||
| Q2 24 | — | $0.04 | ||
| Q1 24 | — | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $40.6M | $13.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $594.6M | $141.5M |
| Total Assets | $937.3M | $199.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $40.6M | $13.5M | ||
| Q3 25 | $46.3M | $11.1M | ||
| Q2 25 | $61.7M | $20.0M | ||
| Q1 25 | $78.7M | $10.2M | ||
| Q4 24 | — | $17.5M | ||
| Q3 24 | — | $11.3M | ||
| Q2 24 | — | $8.8M | ||
| Q1 24 | — | $7.3M |
| Q4 25 | $594.6M | $141.5M | ||
| Q3 25 | $597.9M | $133.6M | ||
| Q2 25 | $668.7M | $139.7M | ||
| Q1 25 | $1.1B | $134.8M | ||
| Q4 24 | — | $131.4M | ||
| Q3 24 | $134.2M | $125.0M | ||
| Q2 24 | — | $119.4M | ||
| Q1 24 | — | $116.3M |
| Q4 25 | $937.3M | $199.2M | ||
| Q3 25 | $987.4M | $202.4M | ||
| Q2 25 | $1.1B | $184.6M | ||
| Q1 25 | $1.5B | $178.1M | ||
| Q4 24 | — | $177.1M | ||
| Q3 24 | $0 | $169.5M | ||
| Q2 24 | — | $163.9M | ||
| Q1 24 | — | $154.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $11.8M | $18.4M |
| Free Cash FlowOCF − Capex | $11.6M | $9.7M |
| FCF MarginFCF / Revenue | 8.2% | 12.7% |
| Capex IntensityCapex / Revenue | 0.1% | 11.5% |
| Cash ConversionOCF / Net Profit | — | 3.27× |
| TTM Free Cash FlowTrailing 4 quarters | $15.9M | $11.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $11.8M | $18.4M | ||
| Q3 25 | $-9.1M | $18.4M | ||
| Q2 25 | $1.5M | $12.3M | ||
| Q1 25 | $12.2M | $2.9M | ||
| Q4 24 | — | $15.0M | ||
| Q3 24 | — | $12.7M | ||
| Q2 24 | — | $10.2M | ||
| Q1 24 | — | $1.2M |
| Q4 25 | $11.6M | $9.7M | ||
| Q3 25 | $-9.3M | $10.7M | ||
| Q2 25 | $1.4M | $4.1M | ||
| Q1 25 | $12.2M | $-12.6M | ||
| Q4 24 | — | $3.2M | ||
| Q3 24 | — | $1.7M | ||
| Q2 24 | — | $1.2M | ||
| Q1 24 | — | $-4.8M |
| Q4 25 | 8.2% | 12.7% | ||
| Q3 25 | -7.6% | 14.9% | ||
| Q2 25 | 1.2% | 6.5% | ||
| Q1 25 | 11.7% | -21.4% | ||
| Q4 24 | — | 5.2% | ||
| Q3 24 | — | 3.0% | ||
| Q2 24 | — | 2.3% | ||
| Q1 24 | — | -9.5% |
| Q4 25 | 0.1% | 11.5% | ||
| Q3 25 | 0.1% | 10.6% | ||
| Q2 25 | 0.0% | 12.9% | ||
| Q1 25 | 0.0% | 26.2% | ||
| Q4 24 | — | 19.5% | ||
| Q3 24 | — | 19.0% | ||
| Q2 24 | — | 16.3% | ||
| Q1 24 | — | 11.9% |
| Q4 25 | — | 3.27× | ||
| Q3 25 | — | 5.23× | ||
| Q2 25 | — | 3.88× | ||
| Q1 25 | — | 1.09× | ||
| Q4 24 | — | 3.47× | ||
| Q3 24 | — | 3.29× | ||
| Q2 24 | — | 6.94× | ||
| Q1 24 | — | 0.73× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
